BiotechTube
Home/Protalix BioTherapeutics/Dror Bashan
DB

Dror Bashan

President & Chief Executive Officer, Director

Protalix BioTherapeutics

Therapeutic Areas

Rare DiseasesLysosomal Storage Diseases

Protalix BioTherapeutics Pipeline

DrugIndicationPhase
Elelyso® (taliglucerase alfa)Gaucher DiseaseApproved
PRX–115 (pegunigalsidase alfa)Fabry DiseaseSubmitted
PRX–119Chronic Granulomatous Disease (CGD)Preclinical

Leadership Team at Protalix BioTherapeutics

GM
Gilad Mamlok
Senior Vice President & Chief Financial Officer
View full Protalix BioTherapeutics profile